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Abstract
Background: The aim of this study was to assess the content validity of a questionnaire to measure melanoma
risk, knowledge and protective behaviour in a convenience sample of Scots and Australians. Australia has the
highest melanoma incidence worldwide but has developed a culture of skin cancer avoidance with a long history
of skin cancer primary prevention campaigns of proven effectiveness. Scotland has lower incidence, but has shown
a greater rate of increase between 1985 and 2007. There is an urgent need in Scotland, therefore, to identify those
groups at greatest risk and provide them with effective preventative advice.
Method: A self-administered postal survey was completed by four groups formed from convenience samples in
two geographical locations (Northeast Scotland and Western Australia). In univariate analysis scores on personal risk,
level of concern, protective behaviour, and knowledge were compared by nationality, previous skin cancer diagnosis
and personally knowing someone with melanoma. Multivariate linear regression analysis modelled the influence of
potential predictor variables upon each of the scores.
Results: 540 people completed the questionnaire, 273 Scots (50.6%). 133 (24.6%) Scots and 83 (15.4%) Australians
previously had melanoma or non-melanoma skin cancer, whilst 120 (22.2%) Scots and 190 (35.2%) Australians
personally knew someone with melanoma. Australians had higher knowledge (p < 0.001), level of concern (p < 0.001)
and protective behaviour (p < 0.001) scores than the Scottish. Australian nationality was the strongest independent
predictor of a higher knowledge score (p < 0.001), followed by a previous skin cancer diagnosis (p = 0.003), personal
knowledge of someone with melanoma (p = 0.011), female gender (p = 0.005) and higher education status (p < 0.001)
(R2 = 0.163).
Conclusion: The questionnaire detected higher levels of knowledge and skin cancer protective behaviours in
Australians than in Scottish people. This was expected and supports the content validity of the questionnaire and
its value as a future research tool in the Scottish population.
Background
The incidence of cutaneous melanoma is increasing in
most Caucasian populations and is viewed as an increas-
ing global public health problem [1,2]. This is particu-
larly so in Scotland where the incidence of melanoma is
increasing rapidly, by 85% in men and 31% in women
between 1983 and 2001 [3,4]. If current trends are
maintained Scottish melanoma incidence rates will dou-
ble every 10-20 years [5]. There is, therefore, a pressing
need in Scotland to identify those most at risk of mela-
noma and provide them with appropriate preventative
advice. Current evidence suggests those previously diag-
nosed with melanoma, those with a family history of
melanoma, and young men of lower socioeconomic and
educational status may benefit from targeted advice
[6-10]. Other factors which could be important,
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however, such as place of residence and occupation,
have yet to be explored in Scotland.
Australia has the highest worldwide incidence of mela-
noma (48.7 per 100,000 people in 2007, compared to 21.1
per 100,000 in Scotland) [11]. Consequently, efforts to pre-
vent melanoma based on sun protection began in the
1960s, much earlier than elsewhere in the world [12]. Co-
ordinated nationwide campaigns began with Slip! Slap!
Slop! in 1980 and were followed by SunSmart, which con-
tinues at the current time, particularly emphasising the
importance of reducing sun exposure in children [3,13,14].
Following sustained effort over three decades, formal eva-
luation suggests that such campaigns have contributed to
changed cultural attitudes with respect to the sun and pro-
tective behaviour, and there is evidence of reduced skin
cancer incidence amongst younger people born after 1960,
when the campaigns first began [3,13,14].
In contrast melanoma prevention efforts in Scotland
have been sporadic and focused on early detection and
treatment rather than prevention [3,6]. Since 2003, how-
ever, Cancer Research UK in conjunction with the UK
government has run the SunSmart campaign, based upon
the Australian model [6,7]. This campaign, however, has
yet to be formally evaluated and may not represent the
best use of resources given the apparent urgency with
which preventative behaviour would appear to need to be
improved amongst those Scottish people at highest risk.
To wait for cultural change to accrue over decades may
not be the best way to approach Scotland’s dramatically
increasing melanoma incidence.
Our aim in conducting this pragmatic study was to
assess the content validity of a questionnaire adapted to
compare personal risk, knowledge and protective beha-
viour with respect to melanoma. Content validity has been
defined as “whether or not the items sampled for inclusion
on the tool adequately represent the domain of content
addressed by the instrument” [15]. We did this by compar-
ing responses from a convenience sample of people in
Australia and Scotland. If proven valid, we believed that
the questionnaire could provide an invaluable research
tool in two respects: first, to identify those groups at great-
est risk of developing melanoma: and second, to gauge the
effect of targeted advice to high risk groups.
Methods
Setting
This study was conducted in Northeast Scotland and in
Perth, Western Australia.
Ethical approval
Full ethical approval for the study was granted by the
North of Scotland Research Ethics Committee (REC
reference number: 08/S0801/13) on February 15 2008,
and by the Human Research Ethics Committee of the
University of Western Australia in April 2008.
Participants
The questionnaire was completed by a convenience
sample of participants drawn from four population
groups which we believed would differ with respect to
melanoma risk and knowledge. The first group com-
prised people from Northeast Scotland that had been
treated for melanoma and had participated in a rando-
mised trial of GP-led follow-up for melanoma. The sec-
ond group comprised people aged between 18 and 80
recruited through three general practices in Northeast
Scotland who, according to their primary care-held
medical records, had never been diagnosed with any
form of skin cancer. The third group comprised people
aged between 18 and 80 who attended one of three
Perth-based GPs. The fourth group comprised people
that had self-referred themselves to a commercial mole
screening clinic in Western Australia. Australian people
previously affected by melanoma and non-melanoma
skin cancers were included in both the third and fourth
groups.
Questionnaire and data collection
The questionnaire had been adapted by us, with permis-
sion, from an existing instrument resulting in a self-com-
pletion questionnaire comprising 28 questions [16,17].
The first six questions gathered data on demographics
and respondents’ personal experience of melanoma. The
remaining 22 questions collected information on four
domains: respondents’ personal risk of melanoma (7
questions); their level of concern about melanoma (i.e.
how often they checked their own skin and how likely
they were to seek medical advice about skin lesions) (4
questions); self-reported behaviour to protect themselves
against melanoma (7 questions), and knowledge about
melanoma (4 questions). For each of the 22 questions
respondents were presented with a range of options,
from which they selected one. Each individual response
attracted a score. Scores within each domain were then
summed to produce four overall scores, personal risk,
level of concern, protective behaviour, and melanoma
knowledge. The approach used to define the summary
scores was intuitive, but grounded in relative effect sizes
from epidemiological meta-analyses [18-24]. Because the
questionnaire used multiple response items, which varied
in the number of responses which people could assign, it
would not have been valid to conduct conventional tests
of internal consistency. The details of potential responses,
the scores associated with each response, the way in
which domain scores were calculated and their ranges
are all shown in detail in Table 1. The questionnaire was
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Table 1 Calculation of personal risk, level of concern, protective behaviour and knowledge summary scores from the
study questionnaire




What happens to your skin in sun? never tans (+6), tans with difficulty (+4), tans easily (+2),
tans always (0)
0 to 6
Does your skin freckle? Yes (+2) or no (0) 0 to 2
How many moles do you have? None (0); less than 20 (+2); more than 20 (+4) 0 to 4
Do you have moles with irregular edge and
colour?
Yes (+2) or no (0) 0 to 2
What is your natural hair colour? black (0), brown (0), red (+2), fair (+1) 0 to 2
What is your ethnic origin Caucasian (+2), Asian (0), Afro-carribean (-2), Chinese (0),
Other - specify (0)
-2 to 2
How many times have you had bad sunburn? Never (0), once or twice (+2), three or more (+4) 0 to 4 -2 to 22
LEVEL OF CONCERN
Have you seen GP with a skin lesion in last 6
months?
Yes (+2) or no (0) 0 to 2
How likely are you to see GP with a skin lesion in
next 6 months?
Very likely (+4), likely (+2), not likely, (0), very unlikely (0) 0 to 4
Do you check your own skin for moles? Yes (+1) or no (0) 0 to 1
If yes, how often? More than monthly (+3), monthly (+2), once or twice a
year (+1)
1 to 3 1 to 10
PROTECTIVE BEHAVIOUR
Do you try to get a suntan at home or on
holiday?
Yes (+1) or no (0) 0 to 1
Do you use a sun bed or sun lamp? Yes (+1) or no (0) 0 to 1
If you use a sun bed or sum lamp, how often? Very infrequently (0), 1-3 times year (-1), monthly (-2),
weekly or more (-3)
-3 to 0
Do you protect your skin at home or on holiday? Yes (+1) or no (0) 0 to 1
How many sunny foreign holidays have you had
in 5 years?
None (+3), one or two (+2), three or four (+1), five or
more (0)
0 to 3
What do you do on noticing a new mole? Visit my GP (+2), ask partner or friend to look at (+1),
ignore it (0)
0 to 2
How quickly should a new mole be checked? < 1 month (+4), < 2 months (+3), <3 months (+2),
eventually (+1), never (0)
0 to 4 -3 to12
MELANOMA KNOWLEDGE
Which of the following 12 factors increase
melanoma risk?1
Correct (+1), don’t know (0), incorrect (0) 0 to 12
How worried would you be if a mole?2 Correct (+1), don’t know (0), incorrect (-1) -3 to 6
Can melanoma be?3 Correct (+1), don’t know (0), incorrect (-1) -4 to 4
Commonest site of melanoma in men or women?
4
Correct (+1), don’t know (0), incorrect (-1) 0 to 1 -7 to 23
1 having lots of moles, a particular diet, fair complexion, alcohol, sunburn, prolonged sun exposure, smoking, blue eyes, green eyes, red hair, fair hair, dark hair.
2 became irregular in shape, became irregular in colour, grew in size.
3 completely prevented, heal without treatment, be cured in treated early, lead to death if not treated.
4 Face, back, leg, other (specify), don’t know.
Please note that questions appearing in the table have been abridged.
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mailed to participants in each of the four groups for self
completion.
Data handling
Paper questionnaires were manually coded prior to entry
into a Microsoft Access database. Data were subse-
quently exported into SPSS version 17.0 for statistical
analysis.
Outcome measures
Outcome measures of the questionnaire are the four
summary scores: protective behaviour, personal risk,
level of concern and melanoma knowledge.
Statistical analysis
All statistical analysis was conducted using SPSS 17.0.
Demographic variables were summarised using percen-
tage (n) or mean (standard deviation) and compared
across nationalities using either the chi square test or the
unpaired t-test. In univariate analysis, since three of the
summary scores (personal risk, protective behaviour and
knowledge) were Normally distributed, they were com-
pared between groups using the unpaired t-test. The
other (level of concern) was non-Normally distributed
and levels were compared using the Mann-Whitney U
test. Multiple linear regression was used to adjust for
gender, nationality, age, having a diagnosis of skin cancer,
personally knowing someone with skin cancer, and edu-
cational status with each of the four summary scores
(personal risk, level of concern, behaviour and knowledge
scores) as the dependent variables.
Results
The demographic characteristics of those completing the
questionnaire are summarised in table 2. The Scottish
respondents were significantly older (p = 0.007) and of
lower educational status (p < 0.001) compared with
the Australian respondents. Significantly more of the
Australian group personally knew someone with skin
cancer (p < 0.001).
Table 3 summarises the univariate comparison of the
four summary scores by nationality. There was no differ-
ence between Australians and Scots in personal risk score.
The median level of concern summary score was signifi-
cantly higher among the Australian participants (p <
0.001), as were the mean summary scores for protective
behaviour (p < 0.001) and knowledge (p < 0.001). Tables 4
and 5 summarises data by a personal diagnosis of skin
cancer (melanoma and non-melanoma skin cancer), and
knowing someone personally with melanoma. Both Aus-
tralians and Scots previously diagnosed with skin cancer
(melanoma and non-melanoma skin cancer) had signifi-
cantly higher personal risk and level of concern than their
non-affected compatriots. In terms of protective behaviour
there was no significant difference between affected and
non-affected Australians, whereas Scots previously diag-
nosed with melanoma reported greater protective beha-
viour than non-affected Scots. Conversely, Australians
previously diagnosed with skin cancer (melanoma and
non-melanoma skin cancer) had greater knowledge than
Australians not affected, but there was no significant dif-
ference between Scots irrespective of a prior melanoma
diagnosis. Australians and Scots who knew someone else
that had been affected by melanoma had significantly
higher personal risk scores and knowledge than those who
did not know someone affected with melanoma. Knowing
someone with melanoma did not appear to significantly
increase level of concern or protective behaviour in either
Scots or Australians.
Multivariate regression analysis was then conducted to
explore the effect of potential modifiers. In each case
nationality, age, sex, educational status, a previous diagno-
sis of skin cancer (melanoma and non-melanoma skin
cancer), and knowing someone else with melanoma were
entered into the model (Table 6). Total model R2 values
were 0.191 for personal risk summary score; 0.303 for
level of concern summary score; 0.179 for protective beha-
viour summary score, and 0.163 for knowledge summary
score. Of factors that independently predicted a higher
personal risk summary score, younger age, having a diag-
nosis of skin cancer (melanoma and non-melanoma skin
cancer), personally knowing someone with melanoma and
a higher level of education were all independent predic-
tors. Neither gender nor nationality significantly predicted
personal risk summary score. However, Australian nation-
ality was an independent predictor of a higher level of con-
cern summary score, along with having a previous
diagnosis of skin cancer (melanoma and non-melanoma
skin cancer), a higher level of education and lower age.
Gender and personally knowing someone with melanoma
did not independently predict the level of concern sum-
mary score. Australian nationality was an independent
predictor of a high protective behaviour summary score,
alongside older age, having had a diagnosis of skin cancer
(melanoma and non-melanoma skin cancer) and a higher
level of education. A higher level of education was an
independent predictor of a high knowledge summary
score, along with Australian nationality, personally know-
ing someone with skin cancer, having had a diagnosis of
skin cancer (melanoma and non-melanoma skin cancer)
and female gender. Age was not a significant predictor of
knowledge summary score.
Discussion
Summary of main findings
Univariate comparison of personal risk of melanoma
scores by nationality revealed no difference between those
Scots and Australians completing the questionnaire.
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In contrast, Australians’ were more concerned about
developing skin cancer, reported higher levels of protective
behaviour and knew more about skin cancer than Scots
and these differences remained following adjustment for
other potential confounders. These results are what we
expected to find and, therefore, appear to support the con-
tent validity of the questionnaire. Of note, the adjusted
analysis suggests that in this sample, even Scots diagnosed
and treated for melanoma knew less and reported less pro-
tective behaviour than unaffected Australians. Again, given
the prevailing cultures in the two countries this is unsur-
prising, albeit somewhat concerning if should it be repro-
duced in a population study. The adjusted analysis also
reveals that in this convenience sample, as expected, being
diagnosed with any type of skin cancer increased concern,
protective behaviour and knowledge. Knowing someone
else diagnosed with melanoma had a lesser effect leading
to increased concern and knowledge, but not self reported
protective behaviour. Again, considering the convenience
samples used these results are what we should have
expected to find.
Context with other literature
We report a study seeking to confirm the content validity
of a questionnaire in a convenience sample of participants
and any comparisons with other literature must be corre-
spondingly tempered and cautious. Nevertheless, the find-
ings are consistent with reports that primary prevention
efforts have succeeded in Australia, especially amongst
younger people where increases in incidence appear to be
levelling off [3]. Conversely, the view that primary preven-
tion and education are currently suboptimal in Scotland
Table 2 Comparison of demographic characteristics between the Scottish and Australian participants
Scottish Australian P-value
Gender
Male 127 (46.5) 115 (43.1)
Female 146 (53.5) 152 (56.9) 0.420
Age mean (SD) 56.8 (15.2) 53.2 (15.5) 0.007
Educational status
No qualifications 46 (17.7) 2 (0.7)
Basic school qualifications 53 (20.4) 10 (3.7)
Higher school qualifications 16 (6.2) 100 (37.5)
Vocational 37 (14.2) 83 (31.1)
Degree/professional 108 (41.5) 72 (27.0) <0.001
Diagnosed with skin cancer
Yes 133 (48.7) 83 (31.1)
No 140 (51.3) 184 (68.9) <0.001
Personally know someone with skin cancer
Yes 120 (44.0) 190 (71.2)
No 153 (56.0) 77 (28.8) <0.001
Values are n (%) unless otherwise stated P-values from chi squared test
Table 3 Univariate comparison of the four summary
scores by nationality
Mean (SD) or median (IQR) P-value
PERSONAL RISK
Scottish 11.37 (3.78)
Australian 11.58 (3.66) 0.517
LEVEL OF CONCERN
Scottish 3.00 (0.00 to 5.00)
Australian 6.00 (3.00 to 8.00) <0.001
PROTECTIVE BEHAVIOUR
Scottish 11.91 (3.23)
Australian 13.64 (2.65) <0.001
KNOWLEDGE
Scottish 11.90 (4.21)
Australian 13.87 (3.14) <0.001
P-values from unpaired t-test or Mann-Whitney U test
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are supported by the data, and is consistent with the con-
tinued rise in incidence here [10]. Two studies, conducted
since the introduction of SunSmart in the UK in 2003,
which lend further credence to our questionnaire should
be mentioned here [6,7]. Both found that young British
men of lower socioeconomic and educational status knew
least about skin cancer, whereas women, the elderly and
those at highest risk were most likely to be concerned
about it. They also reported sub-optimal practice of sun
protection, although women, older people, those of higher
educational status and those at highest risk appeared to be
most proactive. Most worryingly, in 2005, 65% of respon-
dents associated a sun tan with good health [6]. Perhaps in
relation to this, Diffey et al (2009) reported that British
people generally tend to underestimate their personal risk
of skin cancer, and despite high levels of concern, as indi-
cated by high levels of self reported self examination, con-
tinue to practice high risk activities such as sun-bathing
without sunscreen, particularly younger people [7].
Although the data on self examination were encouraging,
taken together these findings are all the more concerning
since those taking part had a personal interest in skin can-
cer due to the recruitment method [7]. Both studies corre-
spond closely to the findings presented here, further
supporting the content validity of the questionnaire.
Neither study explored the effect of personal experience
(either having or knowing someone with skin cancer) on
knowledge and behaviour. Our findings suggest that these
are important and may point the way toward how educa-
tional strategies could be designed in future.
Strengths and limitations
We are quite clear that the purpose of this pragmatic
study was to provide evidence of the content validity of a
questionnaire to measure personal risk, knowledge and
protective behaviour with respect to melanoma. We can
make no claims beyond this. Participants were drawn
purposively from groups between which we would have
expected to have found differences in these domains. In
this respect, we believe that the data appear to show the
questionnaire can detect these differences. Furthermore,
we believe that this has been an important exercise, since
the way in which the questionnaire is designed, with mul-
tiple response items which vary the number of responses
which people can assign, mean that it would not be valid
to conduct conventional tests of internal consistency.
Further, the questionnaire appears to have performed
well amongst both Scottish and Australian people.
Table 4 Univariate comparison of the four summary scores by personal diagnosis of skin cancer
Mean (SD) or Median (IQR) P value
PERSONAL RISK Australian Previous skin cancer 12.30 (3.35)
No previous skin cancer 11.25 (3.75) 0.024
Scottish Previous skin cancer 12.59 (3.60)
No previous skin cancer 10.22 (3.60) <0.001
LEVEL OF CONCERN Australian Previous skin cancer 9.00 (6.50 to 11.00)
No previous skin cancer 5.00 (3.25 to 9.00) <0.001
Scottish Previous skin cancer 4.00 (3.00 to 6.00)
No previous skin cancer 2.00 (0 to 4.00) <0.001
PROTECTIVE BEHAVIOUR Australian Previous skin cancer 13.95 (2.69)
No previous skin cancer 13.50 (2.62) 0.202
Scottish Previous skin cancer 12.96 (2.87)
No previous skin cancer 10.93 (3.26) <0.001
KNOWLEDGE Australian Previous skin cancer 14.47 (2.99)
No previous skin cancer 13.60 (3.18) 0.032
Scottish Previous skin cancer 12.32 (4.20)
No previous skin cancer 11.51 (4.20) 0.115
P-values from unpaired t-test or Mann Whitney U test.
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In both populations it appears to have been understood
and easily completed with very little missing data, despite
a wide range of demographic characteristics. The ques-
tionnaire had been used before but the way we have used
and analysed it, in two discrete geographical regions and
computing four separate summary scores is novel. We
believe that this method of analyzing the questionnaire
can provide meaningful information on separate domains
of a persons’ risk of and attitudes to skin cancer and sup-
ports it use in future Scottish studies to determine where
melanoma prevention advice should be targeted and sub-
sequently evaluated.
Several limitations must be acknowledged. First and
foremost, the four study groups were formed purpo-
sively as described. Therefore, although our data makes
intuitive sense, we make no claims as to its external
validity and generalizability to the general populations of
both countries. That was not our purpose in conducting
this study.
It would have been logical to have explicitly included
a sample of Australian people treated for melanoma.
We did not do this due to a concern that Australian
people with melanoma are an over-researched group.
Data was not collected from all groups at the same
time. Data was collected from Scottish melanoma
patients about two years before the other Scottish group,
with Australian data collection occurring at approxi-
mately the same time. Arguably, therefore this could
mean that differences between the Scottish groups could
have been attenuated by publicity and prevention cam-
paigns in the interim, although differences were still
striking. Also, of the people affected by skin cancer, all of
the Scots had had melanoma, whereas the affected
Australians comprised those affected by all skin cancers.
If anything, this should have biased the study toward the
Scots. With the caveat of the previously discussed metho-
dological limitations the differences we demonstrate
could, therefore, considerably underestimates the true
values within the Scottish population.
Implications
Our data imply that the questionnaire used in this study
has potential as a research tool to guide melanoma pre-
vention efforts, certainly in Scotland. In future, and in
carefully designed population studies, it could be admi-
nistered to large numbers of people. The data thus
Table 5 Univariate comparison of summary scores by personal knowledge of someone with skin cancer
Mean (SD) or Median (IQR) P value
PERSONAL RISK Australian Knew someone with melanoma 11.97 (3.39)
Not know someone with melanoma 10.61 (4.11) 0.007
Scottish Knew someone with melanoma 12.33 (3.22)
Not know someone with melanoma 10.61 (4.02) <0.001
LEVEL OF CONCERN Australian Knew someone with melanoma 6.00 (3.00 to 8.00)
Not know someone with melanoma 4.00 (3.50 to 7.50) 0.172
Scottish Knew someone with melanoma 4.00 (2.00 to 5.00)
Not know someone with melanoma 3.00 (0 to 5.00) 0.071
PROTECTIVE BEHAVIOUR Australian Knew someone with melanoma 13.66 (2.71)
Not know someone with melanoma 13.58 (2.49) 0.875
Scottish Knew someone with melanoma 11.82 (3.08)
Not know someone with melanoma 11.99 (3.36) 0.662
KNOWLEDGE Australian Knew someone with melanoma 14.07 (3.14)
Not know someone with melanoma 13.38 (3.11) 0.001
Scottish Knew someone with melanoma 12.82 (3.88)
Not know someone with melanoma 11.17 (4.33) 0.001
P-values from unpaired t-test or Mann Whitney U test.
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generated could then be used to target resources for
melanoma prevention in the most appropriate way.
Firstly, baseline personal risk domain data could identify
population groups with differential personal risk thereby
allowing efforts to be targeted. In conjunction with base-
line population data on level of concern, melanoma
knowledge and self reported protective behaviour mela-
noma prevention efforts could be directly targeted
where it is most needed. These data could also permit
prevention efforts to be subtly tailored to achieve the
maximum impact. Secondly, once prevention had been
implemented and after a suitable period of time the
questionnaire could be used to assess the impact of
efforts, allowing subsequent redirection of effort if
needed.
Conclusions
We have demonstrated that the questionnaire described
provides meaningful data with respect to melanoma
risk, concern, knowledge and self-reported protective
behaviour and could be useful in future to target and
assess the impact of melanoma prevention efforts.
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